DC - CIK cellular immunotherapy, one of hot research topics on tumor adoptive immunotherapy in recent years, has been implemented in the clinical research, and played a good anti - tumor effect. However, with the supervision of medical ethics review, some potential ethical problems were gradually exposed. To obey basic ethical principles, problems in clinical research could be effectively guided and solved, and with which patients' benefits could be ensured.%DC-CIK细胞免疫治疗为近年来肿瘤过继性免疫治疗研究的热点,已进入临床研究阶段,发挥了良好的抗肿瘤作用.在医学伦理审查的监督下,一些潜在的伦理问题也逐步暴露.坚持基本伦理原则,能够有效指导和解决临床应用中的问题,保护患者的权益.
展开▼
